Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH) 2024-02-08 11:53
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform 2024-02-08 06:11
Complete Genomics and seqWell Announce Codevelopment Partnership at AGBT 2024-02-07 22:00
I-Mab Signs Agreement to Divest its Assets and Business Operations in China 2024-02-07 19:00
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China 2024-02-07 16:35
The Results of Phase II Clinical Study of KN046 in Combination with Nab-paclitaxel in TNBC were Published in Nature Communications 2024-02-07 09:50
SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field 2024-02-07 02:00
SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field 2024-02-07 02:00
Technoderma Medicines Phase 2 Clinical Trial of TDM-105795 Demonstrates Hair Growth in Androgenetic Alopecia 2024-02-05 21:00
Luye Pharma Grants Myung In Pharm Exclusive Rights to Commercialize Rivastigmine Twice Weekly Transdermal Patch in South Korea 2024-02-05 18:53
CARiNG Pharmacy Awarded Gold in Esteemed Putra Aria Brand Awards 2023 in Retail Category 2024-02-05 17:31
Celebrating a Legacy of Care - Pantai Hospital Kuala Lumpur Celebrates 50 Years of Excellence in Healthcare and Unveils Its Future Vision with Gala Dinner 2024-02-05 17:01
Innovent Announces Retirement of CFO and Appointment of New CFO 2024-02-05 16:45
Agilis Robotics Unveils Groundbreaking Advancements in Endoluminal Surgery 2024-02-05 09:53
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy 2024-02-05 08:00
Blossoming Flowers at the Top of the Biopharmaceutical Tree -- Reflections on the Flourishing of Sanyou's 4C Business 2024-02-03 08:00
Lumosa Therapeutics and CHI Memorial announce new study for acute stroke 2024-02-02 22:22
Inmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMED 2024-02-02 22:00
World Cancer Day 2024: RemeGen Announces Three Significant Developments in the Global Fight Against Cancer, Narrowing the Care Gap 2024-02-02 21:30
Results of Phase II Study on Qilu Pharmaceutical's Novel Drug QL1706 Published in Signal Transduction and Targeted Therapy 2024-02-02 17:34
1 16 17 18 19 20 377